Home » Topics » BioWorld Science

BioWorld Science
RSS

Ciba-Geigy advances wound-healing agent into phase II

Sep. 27, 1996

Roche Bioscience-Signal drug discovery collaboration

Sep. 27, 1996

Zambon product pipeline in review

Sep. 27, 1996

SNX-111 development re-scheduled

Sep. 27, 1996

Sanofi reports tachykinin antagonists

Sep. 27, 1996

New tocolytics from Merck & Co.

Sep. 20, 1996

New combination for contraception in males

Sep. 20, 1996

Another new use claimed for raloxifene

Sep. 20, 1996

Vivus seeks approval for impotence treatment

Sep. 20, 1996

Tulane U. investigates GHRH agonists

Sep. 20, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 14, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026